Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Redhill Biophrma ADR (RDHL)

Redhill Biophrma ADR (RDHL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 321,053
  • Shares Outstanding, K 46,395
  • Annual Sales, $ 64,360 K
  • Annual Income, $ -76,170 K
  • 60-Month Beta 1.42
  • Price/Sales 5.02
  • Price/Cash Flow N/A
  • Price/Book 6.09
Trade RDHL with:

Options Overview

Details
  • Implied Volatility 91.50%
  • Historical Volatility 34.54%
  • IV Percentile 1%
  • IV Rank 1.30%
  • IV High 231.92% on 05/11/21
  • IV Low 89.65% on 06/16/21
  • Put/Call Vol Ratio 0.17
  • Today's Volume 27
  • Volume Avg (30-Day) 724
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 26,829
  • Open Int (30-Day) 24,881

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.40
  • Number of Estimates 2
  • High Estimate -0.40
  • Low Estimate -0.40
  • Prior Year -0.45
  • Growth Rate Est. (year over year) +11.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.66 +0.90%
on 05/25/21
7.65 -12.16%
on 06/09/21
-0.33 (-4.68%)
since 05/21/21
3-Month
5.91 +13.71%
on 05/11/21
7.77 -13.51%
on 03/29/21
-0.96 (-12.50%)
since 03/22/21
52-Week
5.91 +13.71%
on 05/11/21
11.52 -41.67%
on 02/22/21
unch (unch)
since 06/22/20

Most Recent Stories

More News
RedHill Biopharma Announces Presentation of Positive Oral Opaganib Phase 2 Data in COVID-19

and , /PRNewswire/ -- (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced presentation of the positive Phase 2 safety and efficacy data for oral opaganib...

RDHL : 6.76 (-2.37%)
RedHill Biopharma to Present at the BIO Digital International Convention

and , /PRNewswire/ -- (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that Mr. , RedHill's Chief Corporate & Business Development Officer, will present...

RDHL : 6.76 (-2.37%)
RedHill Biopharma Completes Enrollment of Oral Opaganib Phase 2/3 COVID-19 Study

and , /PRNewswire/ -- (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has completed enrollment and randomized the last patient in the global...

RDHL : 6.76 (-2.37%)
35 of the Best Ideas Companies to Present at the Summer Solstice - Best Ideas from the Buy-Side Virtual Investor Conference on June 1-4, 2021

The Summer Solstice - Best Ideas from the Buy-Side will take place on June 1-4, 2021, where 35 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor...

RDHL : 6.76 (-2.37%)
PHO : 52.85 (+0.16%)
ECOR : 1.6200 (+2.53%)
MKTY : 6.89 (-9.93%)
SLNG : 8.99 (+0.56%)
CECE : 7.33 (-2.01%)
MKGI : 2.17 (-3.13%)
AUUD : 2.79 (+0.72%)
ARHH : 1.6500 (+0.61%)
DLPN : 8.70 (-1.69%)
IMAC : 1.99 (-4.13%)
COMS : 2.21 (-0.90%)
MYO : 10.23 (+0.79%)
MRVFF : 1.0500 (-7.77%)
MINM : 3.3200 (+11.41%)
DTST : 5.33 (+1.72%)
NLSP : 3.04 (-1.30%)
AWH : 5.58 (-1.41%)
ISDR : 25.07 (unch)
BMRA : 3.86 (-0.89%)
ALIM : 9.25 (-1.07%)
LFMD : 12.39 (+1.47%)
ANDA : 10.51 (+1.55%)
BIOL : 0.7012 (-1.02%)
FBIO : 3.47 (-1.98%)
DHX : 2.89 (-0.86%)
MLSS : 2.0500 (+4.59%)
ORGS : 4.65 (-1.48%)
ELYS : 4.26 (+2.16%)
THBRF : 3.3211 (-2.89%)
NMRD : 8.71 (-6.44%)
DXR : 10.82 (+1.80%)
Strength Seen in Redhill Biopharma Ltd. (RDHL): Can Its 5.4% Jump Turn into More Strength?

Redhill Biopharma Ltd. (RDHL) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price...

RDHL : 6.76 (-2.37%)
RedHill Biopharma Reports First Quarter 2021 Financial Results and Operational Highlights

and , /PRNewswire/ -- (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today reported its financial results and operational highlights for the first quarter ended ....

RDHL : 6.76 (-2.37%)
RedHill Biopharma Ltd. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 27, 2021 / RedHill Biopharma Ltd. (NASDAQ:RDHL) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 27, 2021 at 8:30 AM...

RDHL : 6.76 (-2.37%)
RedHill Biopharma Receives Allowances for U.S. Patent Applications Covering Opaganib and RHB-107 for COVID-19

and , /PRNewswire/ -- (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced receipt of two Notices of Allowance from the U.S. Patent and Trademark Office...

RDHL : 6.76 (-2.37%)
RedHill Biopharma Presents Analyses of Movantik Onset of Action and Symptom Improvement at DDW 2021

and , /PRNewswire/ -- (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced presentation at Digestive Disease Week (DDW) 2021 of two new analyses of Movantik...

RDHL : 6.76 (-2.37%)
RedHill Biopharma Presents a New Travelers' Diarrhea Clinical Severity Classification Tool and its Use in Aemcolo Efficacy Analysis at DDW 2021

and , /PRNewswire/ --  (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced presentation (poster number: Fr244) at Digestive Disease Week 2021 of a new...

RDHL : 6.76 (-2.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

RedHill Biopharma Ltd. is a specialty biopharmaceutical company, focused on gastrointestinal and infectious diseases. It operates through the Commercial Operations segment and the Research & Development segment. The Commercial Operations segment is based in Raleigh, NC, and covers all areas relating...

See More

Key Turning Points

3rd Resistance Point 7.30
2nd Resistance Point 7.21
1st Resistance Point 7.06
Last Price 6.76
1st Support Level 6.82
2nd Support Level 6.73
3rd Support Level 6.58

See More

52-Week High 11.52
Fibonacci 61.8% 9.38
Fibonacci 50% 8.72
Fibonacci 38.2% 8.05
Last Price 6.76
52-Week Low 5.91

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar